AIMOVIG 70mg/ml solution for injection in pre-filled pen EUROPHARM ORIGINAL MEDICINE
Chemical substance: erenumab
Active substance
Results for the substance erenumab
3 results
About this active substance
Erenumab is a medication used for the prevention of migraine in adults. It works by blocking the CGRP receptor, a protein involved in triggering and maintaining migraine attacks.
Erenumab is administered as subcutaneous injections once a month, according to the neurologist's instructions. The dose may be adjusted depending on the patient's response to treatment.
Side effects may include injection site reactions, constipation, muscle cramps, or, rarely, severe allergic reactions. Medical monitoring is recommended throughout the treatment.
Erenumab is a modern and effective option for migraine prevention, helping to reduce the frequency and intensity of attacks and improve patients' quality of life.
Erenumab is administered as subcutaneous injections once a month, according to the neurologist's instructions. The dose may be adjusted depending on the patient's response to treatment.
Side effects may include injection site reactions, constipation, muscle cramps, or, rarely, severe allergic reactions. Medical monitoring is recommended throughout the treatment.
Erenumab is a modern and effective option for migraine prevention, helping to reduce the frequency and intensity of attacks and improve patients' quality of life.
-
-
AIMOVIG 140mg/ml solution for injection in pre-filled pen EUROPHARM ORIGINAL MEDICINE
Chemical substance: erenumab
ATC code: N02CX07 • Nervous system | Antimigraine preparations | Other antimigraine preparations
-
AIMOVIG 70mg/ml solution for injection in pre-filled syringe EUROPHARM ORIGINAL MEDICINE
Chemical substance: erenumab
ATC code: N02CX07 • Nervous system | Antimigraine preparations | Other antimigraine preparations